A carregar...
Targeted Therapies in Non-Small Cell Lung Cancer—Beyond EGFR and ALK
Systemic therapy for non-small cell lung cancer (NSCLC) has undergone a dramatic paradigm shift over the past decade. Advances in our understanding of the underlying biology of NSCLC have revealed distinct molecular subtypes. A substantial proportion of NSCLC depends on oncogenic molecular aberratio...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4491691/ https://ncbi.nlm.nih.gov/pubmed/26018876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers7020816 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|